GROUP ONE TRADING, L.P. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$25,999
-87.6%
8,280
-79.2%
0.00%
-100.0%
Q1 2023$209,440
+238.9%
39,742
+80.7%
0.00%
Q4 2022$61,798
-60.4%
21,992
-41.6%
0.00%
Q3 2022$156,000
+225.0%
37,689
+214.9%
0.00%
Q2 2022$48,000
+860.0%
11,970
+1031.4%
0.00%
Q1 2022$5,000
-98.8%
1,058
-97.5%
0.00%
Q3 2021$425,000
-63.8%
42,495
-48.6%
0.00%
-100.0%
Q2 2021$1,173,000
+41.0%
82,727
+63.3%
0.00%0.0%
Q1 2021$832,000
-36.6%
50,675
-20.1%
0.00%
-50.0%
Q4 2020$1,313,000
+976.2%
63,431
+295.9%
0.00%
Q3 2020$122,000
+713.3%
16,023
+226.5%
0.00%
Q3 2019$15,000
-65.1%
4,907
-54.7%
0.00%
Q4 2018$43,000
-64.5%
10,827
-38.4%
0.00%
-100.0%
Q3 2018$121,000
+476.2%
17,572
+275.1%
0.00%
Q4 2017$21,000
-30.0%
4,684
-3.5%
0.00%
Q3 2017$30,000
-37.5%
4,854
-5.9%
0.00%
-100.0%
Q1 2017$48,000
+37.1%
5,160
+22.7%
0.00%
Q4 2016$35,000
-23.9%
4,205
-37.6%
0.00%
Q3 2016$46,000
+70.4%
6,742
+250.6%
0.00%
Q3 2015$27,0001,9230.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders